Scarica l'app Stockscreener
14.17
0.35%
-0.05
Dopo l'orario di chiusura:
14.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché INMD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$14.22
Aprire:
$14.21
Volume 24 ore:
357.81K
Relative Volume:
0.61
Capitalizzazione di mercato:
$815.40M
Reddito:
$374.64M
Utile/perdita netta:
$87.19M
Rapporto P/E:
10.38
EPS:
1.365
Flusso di cassa netto:
$90.65M
1 W Prestazione:
-0.14%
1M Prestazione:
-5.28%
6M Prestazione:
+3.58%
1 anno Prestazione:
-4.90%
Intervallo 1D:
$14.11
$14.21
Intervallo di 1 settimana:
$14.09
$14.33
Portata 52W:
$12.72
$16.74
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.17 | 820.58M | 374.64M | 87.19M | 90.65M | 1.365 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Iniziato | BTIG Research | Buy |
| 2024-07-23 | Downgrade | Jefferies | Buy → Hold |
| 2023-11-03 | Downgrade | UBS | Buy → Neutral |
| 2023-10-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-02-17 | Downgrade | Needham | Buy → Hold |
| 2022-12-21 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-05-18 | Iniziato | Needham | Buy |
| 2019-09-03 | Iniziato | Barclays | Overweight |
| 2019-09-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-09-03 | Iniziato | Robert W. Baird | Outperform |
| 2019-09-03 | Iniziato | UBS | Buy |
Mostra tutto
Inmode Ltd Borsa (INMD) Ultime notizie
InMode (NASDAQ:INMD) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Avoiding Lag: Real-Time Signals in (INMD) Movement - Stock Traders Daily
Inmode Stock Price Forecast. Should You Buy INMD? - StockInvest.us
InMode Ltd. (INMD) Stock Analysis: Unveiling the Growth Potential in the Medical Devices Sector - DirectorsTalk Interviews
InMode: Reasonably Valued But With Too Much Drama (NASDAQ:INMD) - Seeking Alpha
InMode slips as unsolicited takeover bid expires (INMD:NASDAQ) - Seeking Alpha
Unsolicited acquisition proposal for InMode (NASDAQ: INMD) lapses with no deal - Stock Titan
M.N. Business Strategy, Ltd. cancelled the acquisition of remaining shares InMode Ltd.. - marketscreener.com
Wellington Management Group LLP Invests $1.25 Million in InMode Ltd. $INMD - MarketBeat
Behavioral Patterns of INMD and Institutional Flows - Stock Traders Daily
InMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from Brokerages - MarketBeat
InMode Ltd. Announces Launch Of Morpheus8 Cool On Morpheus8MAX Platform - marketscreener.com
InMode launches Morpheus8 Cool, enhancing RF mi... - Pluang
A new cooling tip brings more comfort to microneedling - Stock Titan
Bank of America Corp DE Sells 236,577 Shares of InMode Ltd. $INMD - MarketBeat
InMode Ltd. (INMD) Key Financial Ratios – Valuation, Profitability & More - Value Research
InMode stock holds steady as investors eye latest growth figures - AD HOC NEWS
InMode Ltd. (INMD) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
InMode (NASDAQ:INMD) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
(INMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - Finansavisen
InMode (NASDAQ:INMD): Is A New Trading Phase Emerging? - Kalkine Media
InMode (INMD) Results Breakdown: The Available Earnings Metric Delivers a Beat in Latest Trading; Investor Response: Shares Close 0.80% Lower on the DayTax Rate Impact - vinanet.vn
InMode (INMD) Holds Steady at $15.15 as Stock Consolidates Between Key Support and ResistanceMomentum Trade - vinanet.vn
InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
154: Static price chart | InMode Ltd. | IL0011595993 - marketscreener.com
North Growth Management Ltd.'s InMode Ltd(INMD) Holding History - GuruFocus
InMode (INMD) wins denial of urgent injunction request in Israeli court - Stock Titan
(INMD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
InMode (INMD) Rises 0.92% to $15.33 as Shares Sit at Midpoint of Key Trading RangeBuyback Factor - dars.gov.et
Cash flow from financing activities of InMode Ltd. – HAM:154 - TradingView
Revenue per share of InMode Ltd. – HAM:154 - TradingView
Long term debt to total equity ratio of InMode Ltd. – HAM:154 - TradingView
Steadtrust LLC Boosts Position in InMode Ltd. $INMD - MarketBeat
Inmode Ltd (INMD) Stock News Today - TradingKey
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK) - The Globe and Mail
InMode Ltd. (INMD) Stock Analysis: Evaluating Growth Potential in the Medical Device Sector - DirectorsTalk Interviews
InMode Ltd. (INMD) CEO holds 4,299,226 shares and extends proposal deadline - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages InMode Ltd. (INMD) Investors to Inquire about Securities Investigation - The National Law Review
InMode (INMD) Stock Margin Compression Deepens As Profitability Fades - simplywall.st
InMode reports stable Q2 2026 revenue at $95.6M, with a 13% rise in consumables sales and $501M cash reserves. - Pluang
Needham Maintains InMode(INMD.US) With Hold Rating - moomoo.com
InMode Ltd. (NASDAQ: INMD) CFO awarded 14,000 RSUs and reports holdings - Stock Titan
InMode (NASDAQ:INMD) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 - Morningstar
InMode Ltd. reports results for the quarter ended June 30Earnings Summary - TradingView
INMODE OUTLOOK FY ADJUSTED EPS USD 1.29-1.34 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Earnings Flash (INMD) InMode Ltd. Posts Q2 Adjusted EPS $0.35 per Share, vs. FactSet Est of $0.33 - marketscreener.com
Earnings Flash (INMD) InMode Ltd. Reports Q2 Revenue $95.6M, vs. FactSet Est of $93.1M - marketscreener.com
InMode: Q2 Earnings Snapshot - marketscreener.com
Inmode Ltd Azioni (INMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):